Global Auto Disable Syringes Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 23.50 Billion |
 Marktgröße (Prognosejahr) | USD 57.65 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
Global Auto Disable Syringes Market Segmentation, By Mechanism (Retractable, Non-Retractable, Others), Clinical Indication (Vaccines, Infectious diseases, Inflammatory/Auto-Immune Diseases, Others), Application (Blood Collection, Vaccination, Drug Delivery, Others), End User (Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Others) - Industry Trends and Forecast to 2031.
Auto Disable Syringes Market Analysis
With the growing concerns regarding the risk of unsafe injections such as unsterilized injection practices UNICEF, UNFPA and WHO decided to introduce the auto disable syringes for immunization in the world. These auto disable syringes are designed to be automatically locked after a single use, hence there is no chance of reuse.
Auto Disable Syringes Market Size
Global auto disable syringes market size was valued at USD 23.50 billion in 2023 and is projected to reach USD 57.65 billion by 2031, with a CAGR of 11.87% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes |
Auto Disable Syringes Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
BD (US), Iscon Surgicals Ltd. (India), AlShifa Medical Products Co. (Saudi Arabia), Hindustan Syringes & Medical Devices Ltd (US), Retractable Technologies, Inc. (US), Smiths Group plc (UK), Baxter (US), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Medtronic (Ireland), Hamilton Company (US), PharmaJet (US), VOGT MEDICAL (Germany), SANAVITA PHARMACEUTICALS GMBH (Germany), JMI Group (Bangladesh), AdvaCare Pharma. (India), ZIBO EASTMED HEALTHCARE PRODUCTS CO., LTD., SWARG PHARMA (India), Nipro Medical Corporation (US), and Boston Scientific Corporation (US) |
|
Market Opportunities |
|
Auto Disable Syringes Market Definition
After a single usage, auto disable syringes are a sort of single-use syringe that is meant to prevent the barrel from depressing again or to break the plunger. These are the types of safety syringes designed to prevent syringe reuse.
Auto Disable Syringes Market Dynamics
Drivers
Major factors that are expected to boost the growth of the auto disable syringes market in the forecast period are as follows:
- Increase in the healthcare expenditure
Due to the rapid acceptance of blood collection and drawing technology, as well as the availability of syringes with better functionality.
- Rise in the infections
Dangers of Infection and spread of life-threatening diseases such as blood-borne infections, HIV, viral hepatitis, and others.
Opportunities
In addition, the rise in the awareness concerning the difficulties of unsafe syringes and rapid technological advancements are further estimated to provide potential opportunities for the growth of the auto disable syringes market in the coming years.
Restraints/Challenges
On the other hand, the decline in the value and dearth of knowledge in advancing economies is further projected to impede the growth of the auto disable syringes market in the targeted period. However, the increased cost of procurement and raw materials might further challenge the growth of the auto disable syringes market in the near future.
This auto disable syringes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the auto disable syringes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Auto Disable Syringes Market
COVID-19 is an unprecedented global public health crisis that has impacted practically every business, with long-term consequences that are expected to stifle industrial growth during the forecast period. The market was negatively impacted in its initial stage, however the rise in demand for syringes for COVID-19 vaccines, projected to total more than 4 billion from the end of 2021 to mid-2022, is owing to the expected surge in COVID-19 vaccine dose deliveries to countries coming through COVAX, along with the large donations from governments, and bilateral deals.
Auto Disable Syringes Market Scope
The auto disable syringes market is segmented on the basis of mechanism, clinical indication, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Mechanism
- Retractable
- Non-Retractable
- Others
On the basis of mechanism, the auto disable syringes market is segmented into retractable, non-retractable and others.
Clinical Indication
- Vaccines
- Infectious diseases
- Inflammatory/Auto-Immune Diseases
- Others
Based on clinical indication, the auto disable syringes market is segmented into vaccines, infectious diseases, inflammatory/auto-immune diseases and others.
Application
- Blood Collection
- Vaccination
- Drug Delivery
- Others
On the basis of application, the auto disable syringes market is divided into hospitals, private practices, outpatient clinics, sports and fitness facility centers and others.
End User
- Hospitals
- Clinics
- Diagnostic Laboratories
- Ambulatory Surgical Centers
- Others
On the basis of end user, the auto disable syringes market is divided into hospitals, clinics, diagnostic laboratories, ambulatory surgical centers and others.
Auto Disable Syringes Market Regional Analysis
The auto disable syringes market is analysed and market size insights and trends are provided by country, mechanism, clinical indication, application and end user as referenced above.
The countries covered in the auto disable syringes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the auto disable syringes market due to the new product launches. Furthermore, the rapid technological advancements and growing adoption of blood collection will further boost the growth of the auto disable syringes market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the auto disable syringes market due to the increase in the product launch. Moreover, the rise in the demand for safe administration of therapeutics in hospitals and clinics is further anticipated to propel the growth of the auto disable syringes market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The auto disable syringes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for auto disable syringes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the auto disable syringes market. The data is available for historic period 2010-2020.
Auto Disable Syringes Market Share
The auto disable syringes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to auto disable syringes market.
Auto Disable Syringes Market Leaders Operating in the Market Are:
- BD (US)
- Iscon Surgicals Ltd. (India)
- AlShifa Medical Products Co. (Saudi Arabia)
- Hindustan Syringes & Medical Devices Ltd (US)
- Retractable Technologies, Inc. (US)
- Smiths Group plc (UK)
- Baxter (US)
- B. Braun Melsungen AG (Germany)
- Terumo Corporation (Japan)
- Medtronic (Ireland)
- Hamilton Company (US)
- PharmaJet (US)
- VOGT MEDICAL (Germany)
- SANAVITA PHARMACEUTICALS GMBH (Germany)
- JMI Group (Bangladesh)
- AdvaCare Pharma. (India)
- ZIBO EASTMED HEALTHCARE PRODUCTS CO., LTD., SWARG PHARMA (India)
- Nipro Medical Corporation (US)
- Boston Scientific Corporation (US)
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
